Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...
Company addresses FDA requests regarding formulation excipient – Global site start-up activities continue, with first-patient-in for registrational Phase 1b study targeted for Q1 2026, subject to FDA ...
Nitro Concepts' first attempt at building an aluminium-based frame has gone well, but needs some work on the surrounding ...
Plus, whether the type of drink affects how quickly your body metabolizes alcohol.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback